Forbes January 15, 2024
Robert Pearl, M.D.

Modern medicine, for most of its history, has operated within a collegial environment—an industry of civility where physicians, hospitals, pharmaceutical companies and others stayed in their lanes and out of each other’s business.

It used to be that clinicians made patient-centric decisions, drugmakers and hospitals calculated care/treatment costs and added a modest profit, while insurers set rates based on those figures. Businesses and the government, hoping to save a little money, negotiated coverage rates but not at the expense of a favored doctor or hospital. Disputes, if any, were resolved quietly and behind the scenes.

Times have changed as healthcare has taken a 180-degree turn. This year will be characterized by cutthroat competition and intense disputes played out in public....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Pricing / Spending, Provider, Technology
FHC #159: Fixing Healthcare flashback with Jonathan Fisher
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
Bird flu: 6 developments to know heading into 2025
Respiratory illnesses surge: 5 updates

Share This Article